Background
BGP Technologies is a fictitious biotech company that provides pharmaceutical consulting, custom drug manufacturing, and a line of consumer medical devices and generic drugs to customers worldwide. It has consulting offices in most of the major cities in the world, including New York, Los Angeles, London, Paris,
Rome, Shanghai, and Mumbai, with manufacturing plants in the United States, China, and Mexico. Recently, the worldwide financial slump has put the company in a difficult position. Before the downturn, the company could absorb the litigation costs associated with its operations as part of the normal cost of doing business; now it can no longer afford to do so. BGP Technologies wants to implement whatever actions it can to avoid or at least minimize some of the legal pitfalls facing it in its worldwide operations
ASSIGNMENT:
Conduct research on what BGP Technologies can do to minimize legal risks associated with:
• Customer credit transactions
• Doing business with customers who may file for bankruptcy protection
• Insuring company property
Create a report of your findings on the risk avoidance strategies related to:
1. customer credit transactions
2. bankruptcy protection
3. insurance
The report should consist of two paragraphs relating to minimizing the legal risks associated with customer credit transactions
The report should consist of two paragraphs relating to minimizing the legal risks associated with bankruptcy protection
The report should consist of two paragraphs relating to minimizing the legal risks associated with insurance.
Required:
2-3 paragraphs each subject area with detailed explanations using cases, case law and relevant examples
USA 
India